An Investigator-initiated Linked Study to OCEANIC-AF

Recruiting Observational Study
Atrial Fibrillation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
East and North Hertfordshire NHS Trust · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Impaired endogenous fibrinolysis is a recently recognised risk factor for thrombotic events in patients with cardiovascular disease. Enhancing endogenous fibrinolysis in such individuals represents a way of reducing thrombosis risk. However, the optimal pharmacotherapy to enhance fibrinolysis is unclear. The aim of this study is to assess the effect of asundexian on endogenous fibrinolysis and co…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients aged 18 years or over 2. Patients enrolled in OCEANIC-AF study 3. Free from the exclusion criteria below 4. The patient is willing and able to understand the Patient Information Sheet and provide written informed consent 5. The patient agrees to comply with the drawi…
Contacts

Joshua H Leader, MBCHB, BSc

07376188768

joshua.leader@nhs.net

CONTACT

Diana A Gorog, MD, PhD

01707247512

d.gorog@imperial.ac.uk

CONTACT